These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15842)

  • 1. Prolongation of rat renal allograft survival by cyclophosphamide and intravenous donor-specific antigens.
    Bramis JP; Schanzer H; Taub RN
    Eur Surg Res; 1977; 9(2):140-54. PubMed ID: 15842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged cardiac xenograft survival is induced by intrathymic splenocyte injection.
    Sheffield CD; Hadley GA; Dirden BM; Bartlett ST
    J Surg Res; 1994 Jul; 57(1):55-9. PubMed ID: 8041149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction and abolition of specific immunosuppression of heart allografts in rats by use of donor blood and cyclophosphamide.
    Marquet R; Heystek G
    J Immunol; 1975 Aug; 115(2):405-8. PubMed ID: 239060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of allograft and xenograft survival by pretreatment with prednisolone and donor-specific antigen.
    Lie TS
    Surg Gynecol Obstet; 1976 Sep; 143(3):369-75. PubMed ID: 60786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New avenues in the use of cyclosporine for transplantation. Graft and donor pretreatment.
    Cederna J; Toledo-Pereyra LH; Gof S; Rios A; MacKenzie GH; Gordon DA
    Immunol Commun; 1984; 13(6):523-38. PubMed ID: 6398274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and portal venous administration of modified donor antigen prolongs rat parathyroid allograft survival.
    Kamei T; Callery MP; Flye MW
    Surgery; 1989 Dec; 106(6):1028-34; discussion 1034-5. PubMed ID: 2588109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of renal allograft survival in the rat by pretreatment with donor antigen and cyclosporin A.
    Homan WP; Williams KA; Millard PR; Morris PJ
    Transplantation; 1981 Jun; 31(6):423-7. PubMed ID: 7020180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats.
    Nakano Y; Monden M; Valdivia LA; Gotoh M; Tono T; Mori T
    Surgery; 1992 Jun; 111(6):668-76. PubMed ID: 1595063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor pretreatment in cadaver renal transplantation.
    Zincke H; Woods JE
    Surg Gynecol Obstet; 1977 Aug; 145(2):183-8. PubMed ID: 327596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of drug timing and histoincompatibility barrier in prolongation of cardiac graft survival in mice treated with donor-specific blood and cyclophosphamide.
    Lasek W; Jakóbisiak M; Płodzisewska M; Szczytnicki W; Górecki D
    Immunol Lett; 1988 Apr; 17(4):357-60. PubMed ID: 3286491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of portal venous injection of donor spleen cells on skin allograft survival in rat.
    Kara E; Gökhan I; Dayangaç M; Ilkgül O; Ertan H; Tokat Y; Terzioglu E
    Indian J Med Res; 2004 Mar; 119(3):110-4. PubMed ID: 15115162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of skin allograft survival in mice after pretreatment with an extract of human platelets in combination with donor antigen.
    Bundschuh G
    Z Exp Chir Transplant Kunstliche Organe; 1987; 20(3):171-6. PubMed ID: 3303708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.